Imaging
Cervical Disc Protrusion
- Preliminary Diagnosis: Cervical Disc Protrusion
-
I. What imaging technique is first-line for this diagnosis?
- II. Describe the advantages and disadvantages of this technique for diagnosis of cervical disc protrusion.
-
III. What are the contraindications for the first-line imaging technique?
-
IV. What alternative imaging techniques are available?
- V. Describe the advantages and disadvantages of the alternative techniques for diagnosis of cervical disc protrusion.
- VI. What are the contraindications for the alternative imaging techniques?
Preliminary Diagnosis: Cervical Disc Protrusion
I. What imaging technique is first-line for this diagnosis?
Noncontrast extradural protocol MRI of the cervical spine in patients without a history of prior neck surgery
In patients with prior neck surgery, the first-line for diagnosis is a contrast extradural protocol MRI of the cervical spine
II. Describe the advantages and disadvantages of this technique for diagnosis of cervical disc protrusion.
Advantages
The patient is not exposed to ionizing radiation.
Are able to differentiate granulation tissue from recurrent disc
Disadvantages
Time consuming
Requires significant patient cooperation to minimize motion artifact
Expensive
III. What are the contraindications for the first-line imaging technique?
Patients who contain non-MR-compatible hardware
IV. What alternative imaging techniques are available?
CT myelography
V. Describe the advantages and disadvantages of the alternative techniques for diagnosis of cervical disc protrusion.
CT myelography
Advantages
May be performed in patients with non-MR-compatible hardware
May be performed much faster than MRI exams
Disadvantages
Exposes the patient to ionizing radiation
Invasive procedure with additional risks
VI. What are the contraindications for the alternative imaging techniques?
CT myelography
Patients allergic to iodinated contrast
Patients with renal failure
Relative contraindication in pregnancy
Copyright © 2017, 2014 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- 9/11 Responders May Have Higher Head and Neck Cancer Risk
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |